Trials / Sponsors / Capsida Biotherapeutics, Inc.
Capsida Biotherapeutics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Suspended | A Clinical Trial of CAP-003 Gene Therapy in Adult Patients With GBA1 Associated Parkinson's Disease GBA1 Parkinson Disease | Phase 1 / Phase 2 | 2025-08-18 |
| Suspended | A Clinical Trial of CAP-002 Gene Therapy in Pediatric Patients With Syntaxin-Binding Protein 1 (STXBP1) Enceph Developmental and Epileptic Encephalopathy | Phase 1 / Phase 2 | 2025-07-03 |
| Withdrawn | Natural History Study in Pediatric Patients with STXBP1 Encephalopathy with Epilepsy STXBP1 Encephalopathy with Epilepsy | — | 2024-10-01 |